Differentiation and metabolism of adipose tissue are modulated by thyroid hormones (THs), but relatively little is known about the metabolism of THs in this tissue. Expression of the genes for type I iodothyronine 5 0 -deiodinase (D1), leptin (LEP) and stearoyl-CoA desaturase 1 (SCD-1) was evaluated in omental (OM) and subcutaneous (SC) fat using a cohort of 70 humans. Activities of iodothyronine deiodinases (D1, D2 and D3) were assessed in a randomly selected subpopulation of 19 subjects. D1 expression was upregulated in both OM (P ¼ 0.011) and SC (P ¼ 0.003) fat of obese subjects. Concomitantly, OM (P ¼ 0.002) and SC (P ¼ 0.028) LEP expression were increased in obesity, associated with both D1 mRNA (r ¼ 0.315, P ¼ 0.014) and activity (r ¼ 0.647, P ¼ 0.023) and inversely related to SCD-1 (r ¼ À0.266, P ¼ 0.034) expression in SC fat. Also D1 (but not D2 and D3) activity was increased in OM (Bfourfold, P ¼ 0.010) and SC (Beightfold, P ¼ 0.004) fat of obese when compared with non-obese subjects and correlated in both OM (r ¼ 0.528, P ¼ 0.036) and SC (r ¼ 0.749, P ¼ 0.005) fat with body mass index. Our results document increased D1 gene expression and activity in adipose tissue of obese humans and suggest a role of 3,5,3 0 -triiodo-L-thyronine formed by D1 in response to leptin in the modulation of adipose tissue metabolism.
Introduction
White adipose tissue represents an important target for thyroid hormones (THs), which are known to support differentiation of fat cells. 1 Moreover, THs modulate adipose tissue metabolism 1, 2 in the context of the calorigenic effect of these hormones in peripheral tissues, which depends in large on fatty acids supplied by adipose tissue via systemic circulation. 3 Multiple biological effects of THs depend on intracellular levels of 3,5,3 0 -triiodo-L-thyronine (T 3 ) acting upon TH receptor. This hormone is mainly generated in peripheral tissues by outer-ring deiodination of thyroxine (T 4 ) by the action of iodothyronine deiodinases (DIOs; EC 1.97.1.10 and EC 1.97.1.11). 4 Both type I and type II iodothyronine 5 0 -deiodinase (D1 and D2, respectively) could catalyze this reaction. D1 is expressed in the liver, kidneys, thyroid gland and pituitary, and is regarded as being an important source of circulating T 3 . 5, 6 However, D1 activity is broader and this enzyme could also form reverse T 3 , an inactive form of T 3 , by T 4 inner-ring deiodination. D2 is mainly present in the brown adipose tissue, placenta, pituitary and muscle, where it is involved in local T 3 production. 6 Type III (D3) 5-deiodinase serves to deactivate THs, while catalysing inner-ring deiodination of T 4 and T 3 to produce reverse T 3 and diiodothyronine (T 2 ), respectively. Relatively little is known about THs metabolism in white adipose tissue, where only D1, but not the other DIOs, were found to be significantly active. [5] [6] [7] Recently, Macek Jilkova et al. 7 demonstrated that the metabolism of THs in murine adipose tissue could be altered under the conditions of changing adiposity, with higher D1 activity detected in obese than in lean mice. Moreover, similarly as in other tissues, 8, 9 both D1 expression and activity in white adipose tissue could be stimulated by leptin, 7 a major adipokine, which is secreted in enhanced rate from hypertrophic adipose tissue and controls food intake and energy expenditure. 10 Leptin also acts directly on peripheral tissues by stimulating fatty acid oxidation and decreasing lipogenesis. 11 In adipose tissue, these metabolic effects may be mediated by stearoyl-CoA desaturase 1 (SCD-1; EC 1.14.19.1), 12,13 a lipogenic enzyme and one of the most sensitive markers of the leptin's action in fat, which is downregulated by leptin. 7, 14 Based on the results obtained in mice, 7 we aimed to characterize mRNA expression and activity of the enzymes involved in THs metabolism in white adipose tissue of humans, and their possible associations with obesity. Therefore, activities of the three known DIOs as well as expression of selected genes were evaluated in adipose tissue in a cohort of human subjects who varied widely in terms of obesity.
In accordance with the results of the animal study, activity of D1 correlated with adiposity. The new data also supported the role of the leptin-D1-T 3 axis in the local control of adipose tissue metabolism.
Research design and methods
Human subjects and samples From a cohort of 70 subjects with a body mass index (BMI) between 20 and 68 kg m
À2
, 42 omental (OM) and 70 subcutaneous (SC) adipose tissue samples (42-paired fat samples) were obtained during elective surgical procedures (cholecystectomy, surgery of abdominal hernia and gastric by-pass surgery) at the Endocrinology Service of the Hospital Universitari Dr Josep Trueta de Girona (Girona, Spain), as previously described. 15 Within these subjects, the samples from a sub-population of randomly selected 19 participants (12 obese and 7 non-obese) were used for measuring DIOs activity. All subjects gave written informed consent after the purpose, nature and potential risks of the study were explained to them. The experimental protocol was approved by the Ethics Committee of the Hospital Dr Josep Trueta of Girona.
Anthropometric measurements
Bioelectric impedance was used to estimate body fat composition as before. 16 According to these anthropometric parameters subjects were classified as non-obese (BMI o30.0 kg m
À2
) and obese (BMIX30.0 kg m
) subjects.
Analytical determinations
The serum glucose levels were measured as before. 15 Free T 4 , free T 3 , and thyroid-stimulating hormone were measured using electrochemiluminescence (ECLIA; Roche Diagnostics, Basel, Switzerland) with intra-and inter-assay coefficients of variation less than 5%.
Gene expression analyses
Gene expression in fat biopsies was assessed by real time PCR as before 16 by thin layer chromatography and quantified using the BAS-5000 laser scanner (Fujifilm Co., Tokyo, Japan). Specific enzyme activities were expressed as femtomoles of respective iodothyronine produced per hour per mg protein.
Statistical analyses
Statistical analyses of the data were performed using Student's t-test. The relationships between quantitative variables were tested using Pearson's correlation coefficient. All values are expressed as mean±s.e.m.
Results
Whole-body characteristics and gene expression in adipose tissue in the entire cohort The anthropometrical and metabolic characteristics of all the participants included in this cross-sectional study are shown in the Table 1 . Except for a higher body fat content and a trend for a higher systolic blood pressure in obese, no significant differences in other whole-body parameters were detected between non-obese and obese individuals, including glycaemia, levels of THs and lipid metabolism markers in plasma.
In OM and SC samples of 70 subjects, expression of D1, LEP and SCD-1 was quantified (Figure 1) . Expression of D1 was significantly higher in both OM (B2.4-fold, P ¼ 0.011) and SC (B2.1-fold, P ¼ 0.003) fat of obese as compared with non-obese subjects ( Figure 1a) . As expected, also LEP expression was significantly elevated in obesity in both OM (B2.1-fold, P ¼ 0.002) and SC (B1.3-fold, P ¼ 0.028) fat (Figure 1b) . Expression of SCD-1 was downregulated in both fat depots of obese when compared with non-obese individuals (Figure 1c ), in parallel with a decrease in expression of other lipogenic genes (that is, the genes for fatty acid synthase and acetyl-CoA carboxylase; data not shown).
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In OM fat, D1 transcript levels correlated with BMI (r ¼ 0.462, P ¼ 0.002) and percent fat mass (r ¼ 0.483, P ¼ 0.001). Also in SC fat, D1 mRNA correlated with BMI (r ¼ 0.265, P ¼ 0.030), as well as with percent fat mass (r ¼ 0.361, P ¼ 0.003). As expected, BMI as well as adiposity correlated with LEP expression in both fat depots (not shown). In turn, in SC fat, LEP expression correlated positively with D1 expression (r ¼ 0.315, P ¼ 0.014) and it was inversely associated with SCD-1 expression (r ¼ À0.266, P ¼ 0.034).
DIOs activity in human fat samples
In a randomly selected subpopulation of 19 individuals (Table 1) , activities of D1, D2 and D3 were estimated in both OM and SC fat depots. Specific D2 and D3 activities were close to the detection limits and there were no apparent differences in these activities between obese and non-obese subjects, independent of the fat depot (data not shown). On the other hand, activity of D1 could be quantitated and it was significantly higher in both OM (Bfourfold, P ¼ 0.010) and SC (Beightfold, P ¼ 0.004) fat of obese when compared with non-obese individuals (Figure 1d ). Indeed, D1 activity correlated with BMI in both OM (r ¼ 0.528, P ¼ 0.036) and SC fat (r ¼ 0.749, P ¼ 0.005).
Discussion
We have demonstrated for the first time in humans that (i) activity of enzymes involved in THs metabolism in adipose tissue differed in subjects according to the degree of adiposity and that (ii) D1, but not D2 or D3, was increased Iodothyronine deiodinases in white fat FJ Ortega et al in obese subjects. Thus, our results are in full agreement with the previous study showing increased D1 activity in association with adipose tissue hypertrophy in mice. 7 Moreover, our results support the hypothesis that the increased levels of D1 in adipose tissue of obese subjects reflects the stimulation of this enzyme by locally formed leptin, and that, in turn, enhanced production of T 3 by D1 in fat could be involved in the modulation of adipose tissue metabolism by leptin. In both, OM and SC fat, expression of D1 as well as D1 activity correlated with BMI, with the biggest (Beightfold) difference between non-obese and obese individuals being in the case of D1 activity in SC fat. The fact that the increase in D1 activity in obese individuals was bigger in SC than in the OM fat is consistent with the higher expression of LEP in SC as compared with OM fat in humans, 17 provided that the increase of D1 may be mediated by the paracrine effect of leptin (see Introduction). In fact, in SC fat of our subjects, LEP expression correlated positively with D1 expression and activity. In spite of the higher D1 activity in SC fat of obese as compared with lean subjects, the previous studies in both human newborns 6 and adult mice, 7 showing several orders of magnitude lower specific activity of D1 in adipose tissue as compared with liver, suggest a relatively little contribution of D1 in adipose tissue to systemic T 3 levels. However, the local production of T 3 in fat depots, mediated by D1 in response to leptin, could be involved in control of metabolism of adipose tissue (see Introduction). Namely lipolysis and fatty acid oxidation in fat depots could be induced by T 3 in concert with leptin, whereas these hormones exert opposite effects on lipogenesis in adipose tissue. 1, 3, 18 Thus, although THs support in situ lipogenesis in fat cells, 1, 3 this process is suppressed by leptin. 18 In agreement with the downregulation of SCD-1 in fat by leptin, 7, 14 we have found a negative correlation between LEP and SCD-1 expression in SC fat, supporting the idea that SCD-1 expression could be downregulated by T 3 formed by D1 (ref. 7 ) and affecting a negative T 3 -response region in the SCD-1 promoter. 19 However, whether T 3 produced in enhanced rate by D1 in hypertrophic fat depots downregulates SCD-1 remains to be verified. The adipocyte-derived leptin and the thyroidal hormone T 3 are key regulators of energy homeostasis and adiposity. 14, 20 Induction of lipid catabolism and lipolysis in adipose tissue by both leptin 18 and T 3 (ref.
3) support further the idea that adipose tissue metabolism may represent a suitable target for treatment of obesity. 7, 18 Our current findings in human fat depots, which are consistent with the previous observations in mice, document increased activity of D1 in hypertrophic adipose tissue and suggest an important role of D1 as a link between leptin and THs in their effects on adipose tissue metabolism.
